12 Infection Control for Immunocompromised Patients

Friday, March 19, 2010: 7:00 AM-8:20 AM
Hanover E (Hyatt Regency Atlanta)
CME Credits: 1.25
Type: Oral
Summary: This session will allow participants to hear updates on current strategies for pharmacologic and environmental aspects of HAI prevention in severely immunocompromised persons. Experts will also discuss the changing epidemiology of HAIs in this patient population.
Learning Objectives:
7:00 AM
Erik Dubberke, MD, Washington University School of Medicine
7:40 AM
Mini Kamboj, MD, Memorial Sloan-Kettering Cancer Center